Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by francois21on May 10, 2014 12:18pm
318 Views
Post# 22547439

RE:GREENCROSS in Quebec,Canada

RE:GREENCROSS in Quebec,CanadaFrankly, I'm trouble with that on the business front for PLI. This happen often to see foreign business receive grants. The difference is that GreenCross is an establish player with the old technology, but for which approval are already received by authorities. PLI still have to go in bio equivalence to prove that PPPS extraction is not inferior to current process. This is not a problem, as PPPS have a better yield recovery, and moreover, a greater purity, as less chimical manipulation is required to extract the proteins. I'm pretty confident that Laval won't be large enought in a few year to supply their proteins orders!
Bullboard Posts